effect of nebulized milrinone and intravenous milrinone in patients with pulmonary hypertention

Comparison effect of nebulized milrinone and intravenous milrinone in patients with pulmonary hypertension who candidate of open-heart surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201104049266N1

Enrollment

Registered

2020-12-06

Start date

2020-11-21

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary HTN. Other secondary pulmonary hypertension

Interventions

Intervention 1: Intervention group: Nebulized milrinone- In patients in this group, 2 mg of milrinone (dissolved in dextrose) is diluted in 3 ml of 9% sodium chloride and inhalation is complete withi

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: candidated for open heart surgery pulmonary pressure more than 40 mmhg 20 years <age <70 years

Exclusion criteria

Exclusion criteria: Patient refusal redo surgery COPD Kindey or Hepatic Failure LVEF25mmhg

Design outcomes

Primary

Measure	Time frame
Mean pulmonary artery pressure. Timepoint: During surgery. Method of measurement: Using a radial artery catheter and a pulmonary artery catheter and through the left internal jugular vein.;Pulmonary capillary wedge pressure. Timepoint: During surgery. Method of measurement: Using a radial artery catheter and a pulmonary artery catheter and through the left internal jugular vein.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Joreirahmadi

Ahvaz University of Medical Sciences

sjaca4913@gmail.com+98 61 3374 3030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026